Observational Study to Evaluate the Safety and Efficacy of NovoMix® 70 in Type 2 Diabetes

NCT00704223 · clinicaltrials.gov ↗

COMPLETED

Status

619

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 2

Interventions

DRUG: biphasic insulin aspart

Sponsor

Novo Nordisk A/S